UK solid state battery developer Ilika has signed a deal with Cirtec Medical to build Stereax mm-scale batteries in the US.
Production at the plant in Massachusetts will boost Cirtec’s ongoing activities in system level miniaturization for the medical device industry. Ilika will focus on advanced technology development and IP licensing to support Cirtec’s manufacturing and commercialization activities.
The Stereax product line is designed for miniature medical implants and specialist Internet of Things (IoT) applications with a technology that is intrinsically safe, long life (1000s recharges), low leakage (nA) and miniature power source in a rectangular form factor similar to integrated circuits.
- Ilika scales up for UK solid state battery production
- Ilika ships first samples of millimetre solid state battery
Cirtec Medical is a vertically integrated outsourcing company providing end-to-end product design, development, and manufacturing of Class III and II medical devices and components. These include neuromodulation, implantable drug delivery, cardiac rhythm management, ventricular assist and interventional devices and delivery systems. The company has manufacturing across the US and in Birkenfeld, Germany.
“Our partnership with Cirtec reinforces a pathway towards commercialization of our Stereax battery technology,” commented Graeme Purdy, Ilika Chief Executive Officer, adding, “Cirtec brings a wealth of manufacturing experience and a strong track record of successful product commercialization in the medical device industry to our partnership.”
“With over 20 years of experience in the design, development, and manufacturing of medical devices, Cirtec is uniquely poised to work with Ilika in bringing its Stereax battery technology to market. We believe this collaboration fits right into our strengths and expands upon our mission to vertically integrate our capabilities to support our offerings to the implantable and wearable device markets,” said Brian Highley, Cirtec Medical Chief Executive Officer.